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ABSTRACT
Despite impressive advances in the field of allogeneic hematopoietic transplantation, graft versus host disease
(GVHD) remains a significant obstacle to be overcome; it would enhance the safety and efficacy of this
life-saving therapy. This review provides a framework for understanding the molecular and cellular basis
underlying GVHD. We propose a 3-phase model of GVHD that highlights the importance of the conditioning
regimen on the recipient tissues administered prior to infusion of donor bone marrow inoculum. A novel skin
explant model, designed to take into consideration the immunobiological consequences of conditioning
regimens on resident host cells, is proposed to advance our understanding of GVHD and serve as a potential
prognostic tool when allogeneic recipient/donor combinations are being contemplated in the clinic. Within
this review, specific emphasis is placed on the importance of defining the apoptotic machinery engaged in
epidermal keratinocytes triggered by both conditioning regimens, and by host resident and recruited immu-
nocytes and soluble mediators produced at sites of injury. The review is completed with a working model for
cutaneous GVHD. Although the skin is highlighted because of its accessibility for clinical observations and
serial sampling opportunities, lessons learned from studies of cutaneous GVHD are likely to provide valuable
insights into GVHD occurring in the gastrointestinal tract, lung, and liver. With new insights designed to
better predict and prevent GVHD and novel agents designed to treat GVHD, overcoming this current
impediment to successful bone marrow transplantation should become increasingly feasible.
© 2004 American Society for Blood and Marrow Transplantation
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tNTRODUCTION
Graft-versus-host disease (GVHD) is the principal
oxicity of allogeneic bone marrow transplantation
BMT). Acute GVHD primarily affects 5 target or-
ans: skin, gastrointestinal tract, liver, host lympho-
oiesis, and lung. Clinically, acute GVHD of the skin
esults in an erythematous desquamating rash that
haracteristically involves the palms, soles, and trunk.
istopathology of involved skin may reveal focal or
iffuse vacuolization of the basal cell layer (grade I);
pongiosis and dyskeratotic keratinocytes (KCs) in
lose proximity to epidermal lymphocytes (aka satel-
66ite cell necrosis; grade II); necrotic KCs with pyknotic
uclei and eosinophilic cytoplasm, often with subepi-
ermal cleft formation (grade III); and, ﬁnally, a com-
lete loss of the epidermis (grade IV) [1]. Despite
normous strides in basic immunologic sciences, the
revention, diagnosis, and treatment of acute GVHD
as remained unchanged in the past 2 decades.
The pathophysiology of acute GVHD in the skin
an be considered as a 3-phase process, shown sche-
atically in Figure 1. In phase 1, the conditioning
egimen (irradiation, chemotherapy, or both) is pos-
ulated to initiate the damage of host tissues through-
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GVHD of the Skin
But the body and the production of danger signals,
ncluding secretion of the inﬂammatory cytokines tu-
or necrosis factor (TNF)– and interleukin-1 [2,3],
s well as heat shock proteins [4]. These danger signals
ctivate resting dendritic cells (DCs) and enhance the
xpression of HLA-DR and various adhesion and co-
timulatory molecules [5,6]. Inﬂammatory cytokines
ay also stimulate the release of chemokines that can
xpedite the recruitment of donor T-cell effectors into
he skin. The infusion of an allogeneic bone marrow
noculum initiates phase 2, wherein activated host
Cs present alloantigens to donor T cells. In Figure
, HLA-DR is both a marker of DC activation and the
lloantigen recognized by the T-cell receptor on the
onor T cells. Activated donor T cells further stimu-
ate DCs through the engagement of co-stimulatory
athways such as CD40:CD40L, which in turn en-
ance T-cell stimulation and clonal expansion. In
hase 3, the histopathologic changes of acute GVHD
n the skin become apparent when KCs undergo pre-
ature apoptosis. Inﬂammatory cytokines such as
NF- and interleukin-1 are major effectors of this
rocess. These cytokines not only damage KC targets,
ut also perpetuate the activation of host DCs in a
VHD ampliﬁcation loop between phase 2 and phase
(“cytokine storm”). This framework provides a basis
or investigation of the precise molecular and cellular
nteractions that mediate acute GVHD and may help
igure 1. A 3-phase model is proposed for the pathogenesis of cutan
anger signals in skin by triggering either KC death or the releas
ctivated DCs. Expression of co-stimulatory molecules is accompani
olecules. In phase 2, after BMT, donor T cells recognize alloan
ytokines and other factors and culminating in premature apoptos
ostulate that keratin-15 KCs with stem cell–like properties are p
icious cycle is established wherein initial KC cytotoxicity is accom
urther enhances host DC activation and donor T-cell cytokine rele
he basal layer to include suprabasal layer KCs.o develop new strategies to prevent, diagnose, and o
B&MTreat this intractable and toxic complication of alloge-
eic BMT.
HASE 1: EFFECT OF CONDITIONING REGIMENS ON
UBSEQUENT DEVELOPMENT OF GVHD
The intensity of the conditioning regimen is a risk
actor for acute GVHD. In patients with severe aplas-
ic anemia, those who received irradiation had a
igher risk of acute GVHD than those who received
hemotherapy alone as induction therapy [7]. In pa-
ients with hematologic malignancies, higher doses of
otal body irradiation correlate with an increased risk
f GVHD [8,9]. The role of ionizing radiation in the
evelopment of experimental GVHD was explored in
ne study that identiﬁed a synergistic effect in which
reradiation exacerbated subsequent GVHD in mu-
ine skin [10]. Although several reports have docu-
ented the ability of chemotherapeutic drugs to affect
he epidermis, the primary focus of these investiga-
ions has been to distinguish the cytotoxic effects of
he drugs from GVHD [1,11-14]. Somewhat surpris-
ngly, these studies did not move beyond this mor-
hologic and diagnostic conundrum to probe the re-
ationship between conditioning and the development
f GVHD. As detailed in the following sections, we
peculate that the effect of radiation is important not
VHD. In phase 1, the conditioning regimen is postulated to create
tokines and other soluble mediators that convert resting DCs to
hanced expression of major histocompatibility class I and II surface
displayed on activated host DCs in skin, triggering the release of
s located predominantly in the rete ridges of the epidermis. We
arly vulnerable to the premature apoptotic reaction. In phase 3, a
by ampliﬁed cytokine secretion to produce “cytokine storm” that
us exacerbating KC cell death that ultimately spreads upward fromeous G
e of cy
ed by en
tigens
is of KC
articul
panied
ase, thnly for the damage caused to epidermal KCs, but also
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368or the activation of normal resting DCs in the dermis
hat provides the critical context for the alloreaction
nitiated by infusion of donor T cells in phase 2.
HASE 2: HIGH-DOSE RADIATION ACTIVATES SKIN
CS AND CAUSES T-CELL STIMULATION IN MIXED
YMPHOCYTE REACTIONS
To explore the effect of conditioning regimens on
ntigen-presenting cells in human skin, we devised a
kin explant model system in which punch biopsy
amples of normal human skin were exposed to 12 Gy
f irradiation (to simulate a BMT conditioning regi-
en) and then maintained in culture for 24 hours.
fter culture, cytospin preparations were stained for
he activation marker HLA-DR as shown in Figure 2.
n the absence of irradiation (panel A), DCs did not
xpress HLA-DR. By contrast, after irradiation (panel
), there were numerous HLA-DR cells, many of
hich had DC morphology, as assessed by light mi-
roscopy after immunohistochemical staining of cyto-
pin preparations.
After the 24-hour incubation, biopsy specimens
ere minced, made into a single-cell suspension, and
ransferred into 96 round-bottom wells. Each well
ontained 5000 epidermal-derived cells (EDCs) that
erved as stimulators and 1  105 allogeneic periph-
ral blood mononuclear cells (PBMCs) that served as
esponders. As shown in Figure 2C-F, the ability of
rradiated EDCs to activate allogeneic donor PBMCs
as assessed by visual inspection for blastogenesis (day
), by enzyme-linked immunosorbent assay measure-
ent to detect interferon (IFN)– in the supernatant
day 3), and by thymidine incorporation to measure
-cell proliferation (day 7). Neither proliferation (97
ounts per minute [cpm]) nor IFN- production (8
g/mL) was observed in the negative control wells
donor PBMCs alone), whereas the positive control (a
idirectional mixed lymphocyte reaction) fostered sig-
iﬁcant allogeneic T-cell responses (5923 cpm; IFN-
1000 pg/mL). EDCs from unirradiated skin were
ot capable of stimulating allogeneic T cells in these
ultures (Figure 2E), whereas skin irradiated with 12
y (Figure 2F) caused signiﬁcant T-cell proliferation
nd IFN- production (1164 cpm; IFN- 87.6 pg/
roliferation was conﬁrmed by enhanced 3H-thymidine incorpora-
ion (5823 cpm), and IFN- release was also high (1000 pg/mL).
, Combination of unirradiated skin cells with allogeneic PBMC
howing no signiﬁcant T-cell proliferation (lack of colonizing for-
ation and also 120 cpm of 3H-thymidine incorporation) and no
FN- release (8 pg/mL). F, Combination of epidermal and der-
al cells derived from irradiated skin combined with allogeneic
BMC, in which phase contrast microscopy reveals blastogenesis
onﬁrmed by enhanced 3H-thymidine incorporation (1164 cpm).
his was accompanied by IFN- production (87.6 pg/mL).igure 2. Novel skin explant model system designed to detect the
mmunobiological consequences of conditioning regimens on resi-
ent host cells. In this ex vivo model system, 6-mm punch biopsy
amples of healthy human skin are placed in phosphate-buffered
aline and exposed to 12 Gy of gamma irradiation as a single dose,
ollowed by suspension in X-VIVO 15 medium for 18 hours at 37°C
n a humidiﬁed incubator. Next, the tissue is minced and digested
ith a cocktail of enzymes including collagenase, hyaluronidase, and
eoxyribonuclease for an additional overnight incubation at 37°C.
fter ﬁltering through a mesh screen, total cells are counted and
ither used for cytospin preparations to detect HLA-DR on DCs (A
nd B) or added in triplicate wells to round-bottom 96-well plates to
erve as stimulator cells (5  103 cells per well) and combined with
llogeneic Ficoll-Hypaque–derived peripheral blood mononuclear
ells (PBMCs; 1 105 cells per well). After 3 days of co-incubation,
0 L of the 200-L total reaction volume is removed for enzyme-
inked immunosorbent assay to detect IFN- levels, and 2 days
ater, 1 Ci of 3H-thymidine is added. The cells are harvested the
ollowing day to assess T-cell proliferation (C-F). A, Microscopic
ppearance of DCs produced from cytospin preparations of unirra-
iated skin that do not express HLA-DR. B, Immunohistochemical
taining of cytospin preparations from irradiated skin in which DCs
trongly and diffusely express HLA-DR. C, Negative control in
hich the phase microscopic appearance reveals a uniform cluster of
ound cells in the bottom of the well, with minimal 3H-thymidine
ncorporation (97 cpm) and no signiﬁcant IFN- production (28
g/mL). D, Positive control in which 2 different PBMC donors
ere combined to generate a 2-way mixed lymphocyte reac-
ion characterized by blastogenesis, as seen by colonies of acti-
ated appearing immunocytes by phase contrast microscopy. T-cell
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GVHD of the Skin
BL). Thus, high-dose radiation resulted in the acti-
ation of skin DCs and the subsequent stimulation of
llogeneic T-cell responses. Whereas our studies used
uman skin and immunocytes, another group has ob-
erved that gamma irradiation can inhibit IFN-.
hus, additional studies are indicated to further eval-
ate the immunomodulatory effects of gamma irradi-
tion on cell-mediated immune reactions in human
kin.
Prior studies have suggested that factor XIIIa–
ositive dermal dendrocytes may be involved in the
athogenesis of disorders involving antigen presenta-
ion to T cells and dermal ﬁbrosis [16]. Proof by
ssociation of increased activity of dermal dendrocytes
as been provided by Yoo et al. [17] in an experimen-
al murine GVHDmodel. Because some cases of acute
utaneous GVHD occur with only rare T cells present
n lesional skin, it is possible that direct contact be-
ween cytotoxic T cells and KCs may not entirely
xplain the epidermal damage in GVHD. Further-
ore, the distance between effector cells in the der-
is, such as activated T cells and DCs, and epidermal
argets, such as KCs, implies that soluble mediators
eleased by immunocytes may mediate KC apoptosis.
t is also possible that death ligands expressed by
ctivated DCs, such as TNF-related apoptosis-induc-
ng ligand, may contribute to KC apoptosis [18,19].
f course, in animal models, investigators have also
stablished that both CD4 and CD8 T-cell subsets
ossess cytotoxicity against epidermal cells in experi-
ental GVHD [20-22].
HASE 3: PREMATURE BASAL CELL KC APOPTOSIS
N GVHD
The process of apoptosis or programmed cell
eath is a natural event critical to homeostasis of all
rgan systems, including skin. To maintain a constant
nd functional epidermal thickness, the rate of cell
roliferation must be matched to the rate of cell death
nd desquamation. The barrier function of the epider-
is mandates that the timing of cell death be precisely
oordinated in a 3-dimensional spatial context. The
asal layer contains a subpopulation of cells similar to
tem cells. They have a high proliferative potential, as
ndicated by retention of tritiated thymidine [23-25],
re located in a protected bulge area of the hair follicle
r interfollicular basal layer [26-28], and produce
aughter cells that undergo a ﬁnite number of cell
ivisions before they differentiate [29]. Thus, KCs
sually cannot prematurely undergo apoptosis in the
asal layer (stratum spinosum) because this would per-
urb both epidermopoiesis and corneogenesis [30,31].
any studies document the presence of various com- B
B&MTonents of the apoptotic machinery in healthy human
kin: Bcl-x [32], Fas [33,34], TNF- [35], TNF re-
eptor-1 [36], and activated caspase-3 [37].
aspase-14 has also been documented in healthy mu-
ine skin [38].
The damage to epidermal KCs in GVHD of the
kin occurs in a nonrandom fashion. Sale et al. [39]
rst observed in 1985 that KCs at the edge of the
pidermis in the tips of rete ridges are the preferred
arget population in cutaneous GVHD. They sug-
ested that these damaged KCs may represent stem
ells. In a similar vein, Kim et al. [22] have recently
ocumented vascular cell adhesion molecule-1
CD106) expression on a distinctive subpopulation of
Cs at the tips of retelike prominences in dorsal
ingual epithelium that were highly susceptible to ap-
ptosis in a murine model of acute GVHD. Basal cells
n the rete ridges of normal human skin are positive
or keratin-15 [40], a marker that has recently been
inked to stem cells in skin by Lyle et al. [41]. In
urther studies, Whitaker-Menezes et al. [40] demon-
trated selective apoptosis of keratin-15 KCs located
t the tips of retelike prominences in a murine model
f GVHD. These retelike prominences in the lingual
pithelium of the mouse represent a microdomain
ery similar to rete ridges of human skin. The authors
mphasized that the mode of KC cell death in GVHD
as due to the induction of apoptosis, as opposed to
ecrosis.
These data suggest that GVHD causes premature
ctivation of apoptotic machinery in basal KCs at the
dge of the epidermis. In cells undergoing pro-
rammed cell death, the activation of caspase-3 occurs
s a downstream event that links both extrinsic (death
eceptor–mediated) and intrinsic (mitochondrial- or
NA damage–mediated) apoptotic pathways. We rea-
oned that the presence of activated caspase-3 in a cell
ould not only identify it as apoptotic, but also indi-
ate the activation of the apoptotic machinery in-
olved in the premature demise of the targeted cell.
e therefore stained GVHD skin with a commer-
ially available antibody that recognizes only the acti-
ated, or cleaved, form of caspase-3 [42]. Apoptotic
Cs identiﬁed by the uptake of the activated caspase-3
ntibody, as well as by the terminal deoxynucleotidyl
ransferase–mediated deoxyuridine triphosphate nick-
nd labeling assay in GVHD lesional skin, were pref-
rentially located at the base of the rete ridges; this
onﬁrmed apoptosis as the mode of basal KC death in
VHD (B. Nickoloff, unpublished data). These ex-
erimental results support the notion that the condi-
ioning regimen activates the apoptotic machinery in
he basal KC layer, thereby making these cells more
ulnerable to apoptosis when GVHD develops after
MT.
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3N INTEGRATED HYPOTHESIS OF GVHD
ATHOPHYSIOLOGY IN THE SKIN
Taken together, these data suggest a reﬁned and
ntegrated hypothesis for the mechanism of target cell
poptosis during acute GVHD (Figure 3). In phase 1,
he conditioning regimen produces 2 distinct but re-
ated effects in the skin. First, it activates DCs in the
ermis, priming them for an alloreaction that may
ccur when donor T cells are infused at the time of
ransplantation. Second, the apoptotic machinery in
asal KCs is activated. During autologous BMT,
hen no alloreaction occurs, DC activation is self-
imited, apoptotic machinery disengages, the basal
Cs recover, and normal epidermopoiesis is restored.
uring an allogeneic BMT, donor T cells respond to
he activated host DCs in the dermis. Inﬂammatory
ediators such as TNF- are produced that maintain
ngagement of the activated apoptotic machinery in
asal KCs and ultimately contribute to premature
poptosis in this cellular compartment. These target
ells thus participate in their own destruction through
he activation of internal death programs, thus helping
o explain the frequent lack of effector cells immedi-
tely adjacent to them.
It should be noted that GVHD can occur without
conditioning regimen. If donor T cells are sufﬁ-
iently stimulated by host DCs, the T cells will further
ctivate the DCs and perpetuate the alloreaction. In
his case, the apoptotic machinery in basal KCs would
ot be activated prematurely; thus, target KC destruc-
igure 3. Working 3-phase model of acute cutaneous GVHD. In
he upper epidermal layers to produce the stratum corneum, and de
s exposed to conditioning regimens (conditioned skin), apoptotic m
anger signals from damaged KCs trigger activation of host DCs (
llogeneic (allo) BMT to generate a cytokine cascade that culmination would take longer to occur, require additional f
70ffector mechanisms, or both. The kinetics of the
istologic change of GVHD in the skin would be
ltered, and the pathology itself might have different
haracteristics. Indeed, anecdotal evidence suggests
hat the manifestations of acute GVHD are different
fter reduced-intensity allogeneic BMT.
We believe that several aspects of our hypothesis
an now be tested both in animal models and in the
linic. The skin is the most frequently biopsied and
est studied target organ of acute GVHD. It repre-
ents an organized epithelial structure that renews
tself and differentiates. Elucidation of the molecular
rocesses that contribute to the destruction of speciﬁc
ubpopulations of target cells may lead to important
nsights not only for skin disease, but also for the other
isceral targets of GVHD. Thus, a better understand-
ng of life and death on the epidermal edge may
ltimately facilitate the development of new strategies
o diagnose, prevent, and treat this difﬁcult complica-
ion of allogeneic BMT.
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